Navan, P., & Bain, P. (2002). Long term tolerability of high dose ergoline derived dopamine agonist therapy for the treatment of Parkinson's disease. BMJ Group.
Dyfyniad Arddull ChicagoNavan, P., and P. Bain. Long Term Tolerability of High Dose Ergoline Derived Dopamine Agonist Therapy for the Treatment of Parkinson's Disease. BMJ Group, 2002.
Dyfyniad MLANavan, P., and P. Bain. Long Term Tolerability of High Dose Ergoline Derived Dopamine Agonist Therapy for the Treatment of Parkinson's Disease. BMJ Group, 2002.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.